Browse By: Country ι Category ι Publisher ι Tag

Vaccine Partnering Terms and Agreements

Pages » 1021
Published By » Current Partnering
Price » $2995
In stock
View Report Details
Description

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines   The report provides a detailed understanding and analysis of how and why companies enter vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the lic... Click here for more details


Bioinformatics Partnering Terms and Agreements
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis
Published Date: Sep 2013
Price: $2995
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jul 2014
Price: $2995
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This rep
Published Date: Jul 2011
Price: $2995
Pharmacogenomic Partnering Terms and Agreements
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analy
Published Date: Apr 2011
Price: $2695
Biomarker Partnering Terms and Agreements
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering a
Published Date: Nov 2014
Price: $2995
Companion Diagnostics Partnering Terms & Agreements
The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed und
Published Date: Nov 2014
Price: $1995
Partnering Terms and Agreements in Diagnostics, 2nd edition
The Partnering Terms and Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and
Published Date: Nov 2010
Price: $2695
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The report provides a detailed understanding and anal
Published Date: Jun 2010
Price: $2695
Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies.   The report p
Published Date: Nov 2014
Price: $2995
Pre-clinical Stage Partnering Terms & Agreements in Pharma, Biotech & Diagnostics
The Pre-clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report detailed understanding and analysis of how and why companies enter pre-clinical stage licensing/business development and other forms of partnering arrangement. The report provides a detailed under
Published Date: Jun 2010
Price: $2695

 


 

Related News

New Innovations in Optics LED
New innovations in the field of lasers and optics have introduced high density white LED light engines for OEM fiber optic illumination. White light LEDs are rapidly becoming the most preferred source for light guide illumination in several technical applications which were once ruled by HID lamps and tungsten halogen. White LEDs offer operational advantages and substantial cost. LumiBright™ delivers up to 4000 lumens into the light guide. LumiBright have no additional optics and couple
Date: Dec 18

‘Fluctuations in Air Freight Impacts Pharma Supply Chains’
Air freight has been considered to be imperative to the pharmaceutical industry more so as supply chains take on a more complex shape. The Life Science and Pharmaceutical conference held in London on Tuesday stressed upon this very fact. Emerging trends such as healthcare at home, increasing clinical trials across the globe, and advanced therapies as well as companion diagnostics have tremendously changed the pharmaceutical industry, according to David Spillet, key account director at World C
Date: Dec 17

Two AC/DC Drivers Launched by ON
On Semiconductor has recently expanded their product line for NCL3008x by launching two new series of offline AC-DC drivers with Power Factor Correction. Their new line of semiconductors includes the new NCL30085/86/88/30. The NCL30030 widens the existing solutions which support higher power topologies. Their primary purpose would be in high performance LED lighting applications. The new line of PFC drivers are said to be small, robust, and flexible. Three of them use a PF corrected algorithm
Date: Dec 17

Different Prospects of New Nuclear Power
Nuclear energy was once promised as the world’s leading source to provide cheap and safe electrical power. However, The United States has led the way in nuclear research due to government finance and support. Some analysts also claimed that electricity would go meterless in the future.   Nevertheless, things did not turn out as decided due to nuclear waste accumulation, accidents, and safety problems, and most of all – rising costs. Despite these problems, growth in nuclear p
Date: Dec 17

Drop in Oil Prices sets off Alarm Bells in Producers and Shareholders
The well-publicized drop in oil prices this week has been celebrated by the masses all over the world as an answer to years of demands. However, the picture is far from rosy on the other side, as oil exporters and shareholders reacquaint themselves with a sub-$60 per-barrel pricing after a considerable hiatus. Increasing amounts of oil production from countries outside the OPEC (Organization of the Petrol Exporting Countries) is loosening OPEC’s stranglehold over the global petroleum ma
Date: Dec 16

Chinese Construction Shares Rise on Stimulus Bets
For the second consecutive day, China’s stocks have risen, led by railway and construction companies. Their growth has been based on the speculation that the government will take improved steps to support economic growth. China Railway Group Ltd. and China State Construction Engineering Corp. gained more than 7 per cent, enough to lead the rise for infrastructure related companies. Meanwhile, Premier Li Keqiang is visiting Kazakhstan to forge a Silk Road Fund that could finance the buil
Date: Dec 15

Citigroup Charges Investors with US$2.7 Billion for Legal Expenses
Citigroup gave its investors a surprise with its 4th quarter results on Tuesday, with an expected US$2.7 billion legal charge associated with multiple investigations. Citigroup has been discussing for settlement with banking regulators and federal prosecutors over a series of investigations connected to possible manipulation in the lax anti-money-laundering controls and the currency market. The 4th quarter charge also reveals the expected cost of a separate inquiry about the role Citigroup an
Date: Dec 10

After Louisiana-Pacific’s Downgrade - What’s next in the Building and Construction Products Industry?
Louisiana-Pacific Corporation was downgraded by the DA Davidson research firm last Friday from a status of “Buy” to a “Neutral” rating, i.e. LPX 0%. RBC Capital had struck a similar rating a few days earlier. It changed its rating from ‘Sector Perform’ to ‘Underperform’ - where the price target was set as $13.00 per share. These implications apply a downside potential of 22 percent from the present price (as of December 8) of $16.85 per share. 
Date: Dec 09

Southern Company Got Warning from State Monitor on Ga. Nuclear Plant Costs
State monitors has warned Southern Co. that building a multi-billion dollar nuclear plant in Georgia without having a comprehensive construction schedule could cause financial penalties. A report was filed by an analyst and an engineer working for state regulators. They supervise the elevation of two new reactors situated at Plant Vogtle in eastern Georgia. The warning was mentioned in that report. The Public Service Commission has notified for at least two years that Georgia Power, a subs
Date: Dec 08

India to Export Carabeef to Russia
According to some recent talks between India’s (APEDA) and phyto-sanitary watchdog Rosselkhoznadzor, Russia has permitted the imports of buffalo meat (carabeef) from India.  This act falls under the Ministry of Commerce and Industry of India. The move is placed a few days ahead of the Russian President’s visit to India. Rosselkhoznadzor in association with the Ministry of Agriculture of Kazakhstan has involved Indian exporters on its buffalo meat import list.  Compani
Date: Dec 08

Upcoming Reports

DNA Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
Vaccines have been in use since decades to provide immunological responses against diseases. A conventional vaccine is a biological preparation of weakened or attenuated, killed forms of a microbe or one of its cellular components, while a DNA vaccine is composed of genetically engineered DNA. Whe
Published By: Transparency Market Research
Price: $4795
HPV Therapeutic Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers
Published By: Transparency Market Research
Price: $4795
Preventable Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
The use of preventable vaccines is to avoid the occurrence of an infectious disease, which is preventable by the use of vaccines. The occurrence of death due to a vaccine-preventable disease is termed as vaccine-preventable death, the reason being failure to attain vaccines in time, lack of access t
Published By: Transparency Market Research
Price: $4795
Foot And Mouth Disease Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
Foot and mouth disease is considered as a highly contagious and severe disease observed in animals with considerable economic impact. Animals which are affected by foot and mouth disease include goat, sheep and cloven-hoofed ruminant. Deer, antelope, elephant and giraffe are susceptible to foot and
Published By: Transparency Market Research
Price: $4795